0001038133-16-000201.txt : 20160304
0001038133-16-000201.hdr.sgml : 20160304
20160304181129
ACCESSION NUMBER: 0001038133-16-000201
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160302
FILED AS OF DATE: 20160304
DATE AS OF CHANGE: 20160304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HESKA CORP
CENTRAL INDEX KEY: 0001038133
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 770192527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0214
BUSINESS ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
BUSINESS PHONE: 9704937272
MAIL ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGinley Michael J
CENTRAL INDEX KEY: 0001392225
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22427
FILM NUMBER: 161486446
MAIL ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-03-02
0
0001038133
HESKA CORP
HSKA
0001392225
McGinley Michael J
3760 ROCKY MOUNTAIN AVENUE
LOVELAND
CO
80538
0
1
0
0
Presi, Biologic. & Pharm.
Common Stock
2016-03-02
4
A
0
14896
0
A
30855
D
Common Stock
2016-03-02
4
F
0
757
33.64
D
30098
D
Includes 12,863 shares issued on March 17, 2015 subject to a performance-based restricted stock grant for which the underlying performance condition has been achieved but the shares have not yet vested and 2,033 shares issued on March 17, 2015 subject to a performance-based restricted stock grant related to Heska Corporation's 2015 Management Incentive Plan for which the underlying performance condition has been achieved and the shares have vested.
Shares withheld to fulfill minimum statutory withholding obligations.
By: Jason A. Napolitano For: Michael McGinley
2016-03-04